Skip to main content
TipRanks
Go Ultimate75% OFF

SQZ Biotechnologies (SQZB) Stock Statistics & Valuation Metrics

149 Followers

Total Valuation

SQZ Biotechnologies has a market cap or net worth of $707.79K. The enterprise value is $13.65M.

Market Cap
$707.79K
Enterprise Value
$13.65M

Share Statistics

SQZ Biotechnologies has 29,491,125 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
29,491,125
Owned by Insiders
―
Owned by Institutions
5.49%

Financial Efficiency

SQZ Biotechnologies’s return on equity (ROE) is -1.39 and return on invested capital (ROIC) is -81.66%.

Return on Equity (ROE)
-1.39
Return on Assets (ROA)
-0.74
Return on Invested Capital (ROIC)
-81.66%
Return on Capital Employed (ROCE)
-0.95
Revenue Per Employee
396.77K
Profits Per Employee
-1.50M
Employee Count
53
Asset Turnover
0.20
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of SQZ Biotechnologies is -0.01. SQZ Biotechnologies’s PEG ratio is -0.00.

PE Ratio
-0.01
PS Ratio
0.03
PB Ratio
0.01
Price to FCF
-0.01
Price to Operating Cash Flow
-0.01
PEG Ratio
-0.00

Income Statement

In the last 12 months, SQZ Biotechnologies had revenue of 21.03M and earned -79.46M in profits. Earnings per share was -2.76.

Revenue
21.03M
Gross Profit
9.79M
Operating Income
-80.68M
Pretax Income
-79.46M
Net Income
-79.46M
EBITDA
-64.14M
Earnings Per Share (EPS)
-2.76

Cash Flow

In the last 12 months, operating cash flow was -74.33M and capital expenditures -213,000, giving a free cash flow of -74.55M billion.

Operating Cash Flow
-74.33M
Free Cash Flow
-74.55M
Free Cash Flow per Share
-2.92

Dividends & Yields

SQZ Biotechnologies pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-11878.01%
Earnings Yield
-11491.38%

Stock Price Statistics

Beta
0.42
52-Week Price Change
0.00%
50-Day Moving Average
0.02
200-Day Moving Average
0.02
Relative Strength Index (RSI)
48.15
Average Volume (3m)
41.62K

Important Dates

SQZ Biotechnologies upcoming earnings date is ―, TBA (Not Confirmed).

Last Earnings Date
Nov 06, 2024
Next Earnings Date
―
Ex-Dividend Date
―

Financial Position

SQZ Biotechnologies as a current ratio of 3.12, with Debt / Equity ratio of 60.14%

Current Ratio
3.12
Quick Ratio
3.12
Debt to Market Cap
0.32
Net Debt to EBITDA
0.46
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, SQZ Biotechnologies has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

SQZ Biotechnologies EV to EBITDA ratio is 0.45, with an EV/FCF ratio of 0.34.

EV to Sales
-1.36
EV to EBITDA
0.45
EV to Free Cash Flow
0.34
EV to Operating Cash Flow
0.34

Balance Sheet

SQZ Biotechnologies has $10.19M in cash and marketable securities with $21.47M in debt, giving a net cash position of -$11.28M billion.

Cash & Marketable Securities
$10.19M
Total Debt
$21.47M
Net Cash
-$11.28M
Net Cash Per Share
-$0.38
Tangible Book Value Per Share
$0.06

Margins

Gross margin is 46.57%, with operating margin of -383.68%, and net profit margin of -377.88%.

Gross Margin
46.57%
Operating Margin
-383.68%
Pretax Margin
-377.88%
Net Profit Margin
-377.88%
EBITDA Margin
-305.01%
EBIT Margin
-360.57%